TASTRIP

Research Project founded by UEFISCDI

PN-III-P1-1.1-PD-2021-0076 

01/04/2022- 31/03/2024 


Figure 1. Western Blot and ICC

2023 - Scientific Report 

Activity 2.2 - Various cell lines of pancreatic origin were tested for their endogenous expression of the targeted receptors: 

By using calcium imaging and specific pharmacological compounds we measured the stimulatory effect in terms intracellular calcium concentration.

Receptors: TAS1R2, TAS1R3, TRPM3, TRPA1, TRPV4, TRPM8, TRPV1.

Cell lines: PANC-1, PC-1, MIA-PaCa-2, U-87 MG, BxPC-3, INS-1, bEnd.3

Activity 2.3 - Investigation of TAS1R2/TAS1R3 endogenous expression in INS-1 pancreatic cells.

By using patch clamp and calcium imaging experiments we measured the cellular and electrical activity of INS-1 cells stimulated with the artificial sweetener, Acesulfame-k.

Acesulfame-K caused an intracellular calcium elevation that was abolished in calcium-free conditions (Fig. 2). 

In voltage-clamp, whole cell configuration, Acesulfame-k produced inward currents that ware diminished by the CaCl channels antagonists, MONNA.

Activity 2.3 - High-throughput screening optimization for identifying novel modulator for the TRPM3 ion channel.

HEK293t cells were transfected with human TRPM3 and GCaMP6m in 96 well plates. Pharmacological compounds from different libraries were applied on the cells after 20 seconds of background reading. The fluorescence determined by intracellular calcium was measured using Flex Station 3.

Until the 1st of December 2023, more than 50 pharmacological compounds were tested for their ability to initiate calcium influx in HEK293t/hTRPM3 cells.

For antagonistic properties of putative compounds, selective TRPM3 agonists were added in each well and the fluorescence was again measured on the whole plate.   



2022 - Scientific Report 

Activity 1.1 - Optimization of sweet taste receptors expression in heterologous systems. 

The sweet taste receptors plasmids where purchased from  Addgene together with the empty vector:  

pcDNA3.1(+)-HA-Flag-natT1R2; 

pcDNA3.1(+)-HLA-Flag-natT1R3; 

pcDNA3.1-HA. 

The plasmids were transfected in HEK293t cells using jetPei transfection reagent in a proportion of 1:1.

For identifying the expression level of the synthetized protein we used Western Blot and Immunohistochemistry (ICC) with anti-FLAG antibody (Fig. 1)

Activity 1.2: - Functional assay optimization for possible TAS1R2/TAS1R3 modulators.

To determine the functional activity of TAS1R2/TAS1R3 various cell lines (HEK293t, COS-7, CHO) were transfected with the receptors using jetPei and Lipofectamine 3000 reagents.

Both calcium and cAMP probes were used to measure the intracellular activity of the transfected cells while stimulated with artificial sweeteners (sucralose, acesulfame-k, neotame)

Project Title: Functional characterization of the sweet taste receptors (Tas1R2/Tas1R3) and TRPM3 in pancreatic beta-cells. 


Type-2-diabetes (T2D) affects more than 400 million people worldwide and it is characterized by the inability of the body to manage glucose blood levels due to insulin resistance. G-protein coupled receptors (GPCRs) represent the largest family of membrane receptors, some of which regulate insulin release due to intracellular calcium increase through the downstream activation of voltage-gated calcium ion channels in pancreatic beta-cells. Transient receptor potential (TRP) channels constitute a class of ion channels that show permeability for sodium and calcium ions. Members of the TRP-melastatin (TRPM) family are expressed in pancreatic beta-cells and contribute to insulin release. The main objective of the proposed project is to find novel modulators of the sweet taste-G-protein coupled receptors (Tas1R2/Tas1R3) and to characterize their interaction with the heat-sensitive TRPM3 channels in pancreatic beta-cells. Both proteins contribute to glucose-dependent insulin release but their physiological functions are yet to be determined. For this purpose we will use a high-throughput screening method to identify specific modulators of the Tas1R2/Tas1R3. By monitoring intracellular calcium and glucose-dependent insulin secretion, we will be able to characterize the interactions between the metabotropic receptors and TRPM3. This approach will provide a better understanding of how these proteins relate to insulin secretion and may lead to novel therapeutic strategies. 

Host Laboratory: Cell Signaling, Insitute of Biochemistry 

Project Team

Project Leader: Dan Domocos, PhD

Project Mentor: Stefana Petrescu, PhD

Volunteers:

Researcher: George Oprita, PhD student

Researcher: Teodora Stratulat, PhD student


Project Chapters

I

Identifying novel specific agonists for Tas1R2 and Tas1R3 receptors. 

Task 1.1 Heterologous expression of Tas1R2/Tas1R3 receptors. 

Task 1.2 Optimization of HTS strategies. 

II

Validation of the lead compounds on endogenously expressed Tas1R2 and Tas1R3.

Task 2.1 Validation of the agonistic properties of the lead compounds identified in Objective 1 on natively expressed Tas1R2/Tas1R3.

Task 2.2 Further corroboration of the lead compounds on primary cell cultures. 

Task 2.3 Effects of Tas1R2/Tas1R3 activation on insulin release. 

III

Characterization  of  the  interaction  between  Tas1R2/Tas1R3  and  TRPM3.

Task 3.1 Expression analyses of the co-expression of TRPM3 channels and Tas1R2/Tas1R3 in β-cell lines.

Task 3.2 Characterisation of the interaction between Tas1R2/Tas1R3 and TRPM3. 

Task 3.3 Interfering with the functional expression of Tas1R2/Tas1R3 and TRPM3 in pancreatic β-cells. 

Project Deliverables

Review Article: TAS1 receptors. An overview of their functions, expression and genetic variations. Opriță George, Babeș Alexandru, Domocoș Dan; Rev. Biol. Biomed. Sci. 2021 4 (1) 59-67; 

DOI: 10.31178/rbbs.2021.4.1.4       

https://rev-biomed.unibuc.ro/2022/08/19/tas1-receptors-an-overview-of-their-functions-expression-and-genetic-variations/

Link

Domocos Dan Tudor, PhD

Web of Science ResearcherID: GRR-9591-2022 

ORCiD: 0000-0003-2574-253X 

Brain Map ID: U-1700-032J-5857 

Researchgate: https://www.researchgate.net/profile/Dan-Domocos-2

Publications:

Inhibition of itch by neurokinin 1 receptor (Tacr1) -expressing ON cells in the rostral ventromedial medulla in mice Published: Aug 2022 in eLife 

DOI: 10.7554/ELIFE.69626 


The Association between TRP Channels Expression and Clinicopathological Characteristics of Patients with Pancreatic Adenocarcinoma Published: Aug 2022 in International Journal of Molecular Sciences DOI: 10.3390/IJMS23169045 


Functional expression of the transient receptor potential ankyrin type 1 channel in pancreatic adenocarcinoma cells (vol 11, 2018, 2021) Published: Apr 2021 in Scientific Reports DOI: 10.1038/S41598-021-88169-9 


Role of 5-HT1A and 5-HT3 receptors in serotonergic activation of sensory neurons in relation to itch and pain behavior in the rat Published: Oct 2020 in Journal of Neuroscience Research  DOI: 10.1002/JNR.24633 


Transient receptor potential ankyrin 1 (TRPA1) positively regulates imiquimod-induced, psoriasiform dermal inflammation in mice Published: Jul 2019 in Journal of Cellular and Molecular Medicine DOI: 10.1111/JCMM.14392 


Signs of chronic itch in the mouse imiquimod model of psoriasiform dermatitis: sex differences and roles of TRPV1 and TRPA1 Published: Jul 2019 in Itch 

DOI: 10.1097/ITX.0000000000000025 


TRPV1 mediates inflammation and hyperplasia in imiquimod (IMQ)-induced psoriasiform dermatitis (PsD) in mice Published: Dec 2018 in Journal of Dermatological Science DOI: 10.1016/J.JDERMSCI.2018.11.009 

Career Summary:

My PhD thesis concerned the effects of serotonin (5-HT) on the peripheral nervous system with implications in itch and pain. In my last five years of scientific research I studied the molecular mechanisms of how touch and pain signals are received and transmitted by the nervous system. My work in the laboratory of Professor Alexandru Babes was mainly focused on thermosensitive ion channels like TRPA1, TRPV1 or TRPM8 expressed in dorsal root and trigeminal ganglia neurons. The investigations that I conducted for my PhD thesis used calcium mircofluorimetry, patch-clamp, cell transfection techniques and behavioral models of itch and pain. By combining these techniques with selective agonists and antagonists for 5-HT receptors I was able to identify the receptor subtypes expressed in rat DRG neurons. These receptor subtypes are responsible for itch signal transduction in the peripheral nervous system.

Projects

PN-III-P1-1.1-PD-2021-0076   2022 - 2024

Functional characterization of the sweet taste receptors (tas1r2/tas1r3) and trpm3 in pancreatic beta-cells.

Coordinating institution:

INSTITUTUL DE BIOCHIMIE (RO)


PN-III-P4-ID-PCE-2020-2411   2021 - 2023

Identification and characterization of the cart-neuropeptide receptor

Coordinating institution:

INSTITUTUL DE BIOCHIMIE (RO)

Project website: https://www.cartp.net/


PN-III-P1-1.2-PCCDI-2017-0797   2018 - 2021 

Pathogenic mechanisms and personalized treatment in pancreatic cancer using multi-omics technologies

Coordinating institution:

INSTITUTUL CLINIC FUNDENI (RO)

Project website: https://cemt.ro/proiect/pancngs/ https://cemt.ro/en/proiect/pancngs-2


PN-III-P4-ID-PCE-2016-0475   2017 - 2019 

Coordinating institution:

UNIVERSITATEA BUCURESTI (RO)

Molecular targets responsible for the pain associated with neurovisceral porphyrias


Research

 DRG, TG and cortical primary neuronal cultures.

 Calcium and voltage imaging.

 Patch-Clamp.

Intracellular signaling.

Behavior



The  signaling  pathway  of  the  TAS1R  heterodimer activation.  When  a  ligand  binds  to  the  TAS1R2-TAS1R3 dimer,  the  G-protein  β3γ13-subunits  subunits  induce  Ca2+  release from the ER via the PLCβ2 and IP3 pathway. The rise in intracellular calcium induces TRPM4 and TRPM5 activation which leads to sodium influx and  ATP release via CALHM1 and CALHM3. Further sodium influx is mediated by VDSCs. The alpha-gustducin subunit induces an increase in cAMP and the activation  of  PKA,  which  phosphorylates  and  thus  inhibits VDKCs.